Dai, Fangfang
Liu, Hua
He, Juan
Wu, Jinglin
Yuan, Chaoyan
Wang, Ruiqi
Yuan, Mengqin
Yang, Dongyong
Deng, Zhimin
Wang, Linlin
Wang, Yanqing
Yang, Xiao
Wang, Huiling
Hu, Wei
Cheng, Yanxiang http://orcid.org/0000-0002-9218-5246
Funding for this research was provided by:
Key Research and Development Program of Hubei Province (2020BCB023)
National Natural Science Foundation of China (82071655, 81860276)
Young Teacher Qualification Project of the Fundamental Research Funds for the Central Universities (2042020kf0088)
Article History
Received: 4 August 2023
Accepted: 24 January 2024
First Online: 20 February 2024
Declarations
:
: All animals were kept in a pathogen-free environment and fed ad lib. And all applicable institutional and governmental regulations concerning the ethical use of animals were followed. The study was performed according to the international, national, and institutional rules considering animal experiments, clinical studies, and biodiversity rights. The study protocol was supported by the program (Preclinical effectiveness of drugs for treatment of premature ovarian failure by direct intra-ovary injection of allogeneic umbilical cord-derived exosomes), and approved by the Ethics Committee of the Renmin Hospital of Wuhan University [No.WDRM animal (f) No. 20210611A]. The date of study approval is June 25, 2021.
: Not applicable.
: The authors have declared that no competing interest exists.